Routes of
administration Oral, IM Biological half-life 3–5 hours Pubchem 5357 ChemSpider ID 5164 | ATC code N05AL02 (WHO) Molar mass 354.46 g/mol ChEMBL ID 277945 | |
 | ||
Trade names Barnetil, Barnotil, Topral AHFS/Drugs.com International Drug Names Legal status In general: ℞ (Prescription only) Routes Oral administration, Intramuscular injection | ||
Sultopride (trade names Barnetil, Barnotil, Topral) is an atypical antipsychotic of the benzamide chemical class used in Europe, Japan, and Hong Kong for the treatment of schizophrenia. It was launched by Sanofi-Aventis in 1976. Sultopride acts as a selective D2 and D3 receptor antagonist. It has also been shown to have clinically relevant affinity for the GHB receptor as well, a property it shares in common with amisulpride and sulpiride.
References
Sultopride Wikipedia(Text) CC BY-SA